Brenda Y. Pacheco, PA-C

Brenda Pacheco practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Brenda Pacheco's NPI, 1992981609, was assigned on January 11, 2008. Brenda Pacheco holds New Mexico license PA2007-0046.

Brenda Pacheco's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Brenda Pacheco's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Brenda Pacheco to 1 more group practice or clinic and 1 medical group, each named with a free account. Brenda Pacheco's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Brenda Pacheco practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Brenda Pacheco's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Brenda Pacheco is licensed in New Mexico.

CMS counts 37 Medicare patients who saw Brenda Pacheco in 2024. The largest group is 65 to 74, with 20 patients. 68% of them have high blood pressure, and 57% have high cholesterol. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Brenda Pacheco's median patient age at 69, with 77% women.

In 2024, Brenda Pacheco wrote 1,356 Medicare Part D claims for 74 patients. 48% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Brenda Pacheco for performance year 2024, reported as part of a group. Brenda Pacheco accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Brenda Pacheco as offering telehealth.

CMS Open Payments shows 13 general payments to Brenda Pacheco from 4 drug and device companies in 2025. Travel and lodging make up the largest share, 73% of the total. Merck Sharp & Dohme Corporation paid the most, $1,355.